Background
The diagnosis of infective endocarditis (IE) was established by using the modified Duke criteria based mainly on echocardiography and blood culture results. No previous studies have compared ICE with TEE for the diagnosis of IE.
Methods
We prospectively enrolled 162 patients (age 72 Ϯ 11 years; 125 male) who underwent transvenous lead extraction: 152 with CDI and 10 with lead malfunction (control group). Using the modified Duke criteria, we divided the patients with infection into 3 groups: 44 with a "definite" diagnosis of IE (group 1), 52 with a "possible" diagnosis of IE (group 2), and 56 with a "rejected" diagnosis of IE (group 3). TEE and ICE were performed before the procedure.
Results
In group 1, ICE identified intracardiac masses (ICM) in all 44 patients; TEE identified ICM in 32 patients (73%). In group 2, 6 patients (11%) had ICE and TEE both positive for ICM, 8 patients (15%) had a negative TEE but a positive ICE, and 38 patients (73%) had ICE and TEE both negative. In group 3, 2 patients (3%) had ICM both at ICE and TEE, 1 patient (2%) had an ICM at ICE and a negative TEE, and 53 patients (95%) had no ICM at ICE and TEE. ICE and TEE were both negative in the control group. The incidence of infection of cardiac rhythm devices has been reported in 0.8% to 19.9% of patients with a previous cardiac device implantation (1) (2) (3) (4) . The complete removal of all hardware is the recommended treatment for patients with established cardiovascular implantable electronic device infection (5) . The main indications for lead removal are cardiovascular implantable electronic device-related endocarditis, local device infection (LDI), and lead malfunction. In particular, the incidence of cardiovascular implantable electronic device-related endocarditis ranges from 20% to 25% of all device-related infections, as described in recent studies (6 -8) .
Conclusions
In clinical practice, the diagnosis of infective endocarditis (IE) is established by using the modified Duke criteria based on clinical and imaging diagnosis; transesophageal echocardiography (TEE) may be a useful tool in this clinical setting (9, 10) . However, the diagnosis of IE can be particularly challenging in cases with prosthetic valves or pacemaker leads, even with the use of TEE (11) (12) (13) . These structures can cause acoustic shadowing and reverberation artifacts, limiting the detection of infective vegetations. The main limitation is the inability to obtain high-resolution images due to the large distance between the transesophageal probe and the right ventricle (far-field limitation) (14) . Because of the increased morbidity and mortality due to a delayed diagnosis of IE, the current European Society of Cardiology (ESC) (9) and American Heart Association (AHA) (10) guidelines recommend repeat TEE examinations in cases of high clinical suspicion of IE if any initial echocardiographic findings are negative. Moreover, the original or modified Duke criteria do not specifically address the diagnosis of cardiac device-related IE (9,10). As proposed by Sohail et al. (2, 7) , the presence of lead vegetation and clinical evidence of LDI could be considered major criteria for the diagnosis of cardiac device-related IE.
Recently, intracardiac echocardiography (ICE) was reported to be useful for the diagnosis of intracardiac vegetation when there is a high clinical suspicion of IE and a negative TEE (15, 16) , but these 2 diagnostic tools have not yet been directly compared. We designed this prospective observational study in patients subjected to transvenous lead extraction to test initial findings regarding the accuracy of ICE compared with standard TEE in the diagnosis of intracardiac masses (ICM).
Methods
Study population and procedural management. We prospectively enrolled 162 consecutive patients (mean age 72 Ϯ 11 years; 125 male) referred to our center from January 2006 to January 2012 for transvenous lead extraction: 152 patients with cardiac device-related infection and 10 patients with lead malfunction (control group). At admission, 68 patients (42%) had an LDI, 63 patients (39%) had LDI and sepsis, and 21 patients (13%) had a diagnosis of sepsis with no evidence of LDI. All clinical data were accurately collected for all patients. Collected data included previous hospital admissions and device implantation, cardiovascular risk factors, pharmacological therapy, clinical presentation related to device infection, echocardiographic parameters, and all procedural data. Blood, swab, and lead-tip cultures were obtained in a sterile manner (5) .
All patients underwent transvenous lead extraction, as described previously (17), following the latest Heart Rhythm Society consensus document recommendations (5), and no surgical lead extractions were performed in these patients.
TEE was performed before transvenous lead extraction on the same day, while ICE was performed right before starting the procedure and ICE monitoring was continued throughout the procedure. Offline TEE and ICE images were presented independently and in randomized order to 2 expert interpreters.
The study was approved by the institutional review board, and all patients gave their written informed consent. Definitions of IE. IE was defined according to the modified Duke criteria, following the current guidelines (9, 10) . A diagnosis of "definite" IE was defined as the presence of either 2 major criteria or 1 major and 3 minor criteria (group 1 patients); a diagnosis of "possible" IE was defined as the presence of either 1 major and 1 minor criteria or 3 minor criteria (group 2 patients); a diagnosis of IE was "rejected" in patients who did not meet the aforementioned criteria for IE (group 3 patients). Moreover, as proposed by Sohail et al. (2, 7) , the diagnosis of definite cardiac device-related IE was obtained in patients with echocardiographic evidence of lead vegetations (without using ICE for the diagnosis of IE) and clinical evidence of LDI.
Finally, due to the lack of a gold standard for the diagnosis of IE, we used both the different criteria (Duke and Sohail) for the diagnosis of IE, to extract from our population with infection a larger number of patients with a definite diagnosis of IE. Transesophageal echocardiography. TEE was performed in all patients in a fasting state for more than 4 h (18). We assessed TEE by using a 5-MHz phased multiplane probe transducer (Philips, iE 33, Andover, Massachusetts) mounted on a flexible monoplane probe connected to a Toshiba Medical System (Artida 2D, Toshiba Medical System, Tokyo, Japan). The pacemaker/defibrillator leads and tricuspid valve leaflets were imaged from the 4-chamber projection, frontal long-axis view of the coronary sinus, and gastric short-axis view. ICM were defined as discrete, echogenic, floating masses found on a valve, lead, or endocardial surface. Intracardiac echocardiography. ICE (19, 20) was performed by using a 10-F probe AcuNav (Siemens Medical Solutions distributed by Biosense Webster, Diamond Bar, California) or 10-F probe SoundStar (Biosense Webster), advanced through a femoral vein percutaneous access in the setting of the extraction procedure, which was performed on the same day as the TEE. These catheters were equipped with a linear phased array multifrequency (5.5 to 10 MHz) transducer, and this was connected to a Sequoia system (Acuson Corporation, Mountain View, California In the group of patients with infection, 78 patients (51%) had fever present at admission, and 133 patients (88%) were already receiving antimicrobial prophylaxis before admission because of fever or clinical evidence of LDI.
In terms of the patients with cardiac deviceϪrelated infection, 44 patients (29%) with a definite diagnosis of IE were included in group 1; 52 patients (34%) with a possible diagnosis of IE were included in group 2; and 56 patients (37%) without a diagnosis of IE were included in group 3. Microbiological data. Bacteriological data regarding the 152 patients with infection are summarized in Table 2 . Blood culture results were positive in 52 patients (34%), swab culture results were positive in 115 patients (75%), and lead-tip culture results were positive in 80 patients (53% Values are n (%) or mean Ϯ SD. CRT-D/P ϭ cardiac resynchronization therapy with/without defibrillator backup; EF ϭ ejection fraction.
Echocardiographic data. The Levene test confirmed the homogeneity of our study population (p ϭ 0.21). In group 1 (definite IE), ICE identified ICM in all 44 patients (100%), whereas TEE identified ICM in 32 patients (73%). In group 2 (possible IE), 6 patients (11%) had ICE and TEE both positive for ICM, 8 patients (15%) had a negative TEE but an ICE finding of ICM, and 38 patients (73%) had ICE and TEE both negative for ICM (p Ͻ 0.001). In group 3 (rejected IE), 2 patients (3%) had ICM both at ICE and TEE, 1 patient (2%) had ICM at ICE but not at TEE, and 53 patients (95%) had no ICM at both ICE and TEE (p ϭ 0.02) ( Table 3 ). ICE and TEE were both negative for ICM in the group of patients with lead malfunction (control group).
Furthermore, by using both the modified Duke and Sohail criteria, we extracted from the population with infection a larger number of patients with a definite diagnosis of IE (58 patients [38%]). In this group, ICE still identified the presence of ICM in all 58 patients (100%), whereas TEE identified the presence of ICM in 38 patients (65%) (Figs. 1A and 1B, Online Videos 1A and and 1B).
Moreover, among the 20 patients with negative TEE but an ICE finding of ICM, 16 (80%) had ICM on the ventricular lead in the tricuspid valve plane in 3 patients (Figs. 2A, 2B , and 2C, Online Videos 2A and 2B); 2 patients (10%) had ICM on the atrial portion of the ventricular lead, also involving the tricuspid valve; 1 patient (5%) had ICM on the ventricular lead within the right ventricle; and 1 patient (5%) had ICM on the atrial lead (Table 4) .
In all 3 groups of patients with infection, ICE identified larger ICM compared with TEE (mean maximum length 16 Ϯ 9 mm vs. 11.5 Ϯ 7 mm, respectively; p ϭ 0.02) (Fig. 3A) , with precise assessment of filamentous masses (Online Videos 3A, 3B, 3C, and 3D). The mean maximum length of ICM identified at ICE was lower in the group with negative TEE compared with the group with positive TEE (8 Ϯ 3 mm vs. 20 Ϯ 9 mm, respectively; p Ͻ 0.001) (Fig. 3B) . Furthermore, no significant differences were found among the 3 Values are n (%).
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groups of patients with regard to the mean maximum length of ICM identified at ICE (17.6 Ϯ 10 mm in group 1; 11 Ϯ 7 mm in group 2; 15.7 Ϯ 7.5 mm in group 3; p ϭ 0.09). A statistically significant correlation was found between the maximum length of ICM values assessed by TEE and ICE (r ϭ 0.95; p Ͻ 0.001). The Bland-Altman plot showed agreement between TEE and ICE methods in the evaluation of the maximum length of ICM, as reported in Figure 4 . Considering TEE as a gold standard for the diagnosis of ICM, ICE had a sensitivity of 100%, a specificity of 82.8%, a positive predictive value of 65.6%, and a negative predictive value of 100%.
In our study population, no lead-related masses were found in the superior vena cava or brachiocephalic vein. Regarding the procedure-related complications, ICE was also able to identify mild pericardial effusions in 2 (1.2%) of 152 patients after lead extraction, without the need for drainage.
Discussion
In this study, we directly compared for the first time the diagnostic yield of ICE versus TEE in the detection of ICM suggestive for vegetation in patients undergoing lead extraction for cardiovascular implanted electronic devicerelated infection. The main findings of our feasibility study are: 1) ICE shows high diagnostic accuracy in the detection of ICM among patients with a definite diagnosis of cardiac device-related IE; 2) in patients with a clinical suspicion of device-related IE undergoing transvenous lead extraction, ICE provides a significantly higher diagnostic power for the detection of ICM compared with TEE; 3) in the group of patients with a high risk of device-related IE according to the modified Duke criteria and the new, not standardized, Sohail criteria, ICE was still able to successfully identify more patients with ICM compared with TEE; and 4) the size of ICM measured at ICE was directly correlated to the size at TEE, although ICE was able to identify significantly larger ICM compared with TEE. TEE plays a major role in the diagnosis of IE, as reported by the current ESC and AHA guidelines (9, 10) , and most studies regarding lead extraction for cardiac rhythm management device infection use this method for the diagnosis of intracardiac vegetations (4, 6, 8, 17) . However, atypical or doubtful results have been obtained by using this method, particularly in the early stage of the disease and in patients with intracardiac devices (11, 14) . In particular, TEE sensitivity for the diagnosis of intracardiac vegetations is suboptimal because a falsenegative result on echocardiogram may be observed in about 15% of patients (9) . The most frequent explanations for a negative TEE are small intracardiac vegetations, vegetations localized on cardiac valves with severe lesions (e.g., mitral valve prolapse and degenerative lesions), nonfloating and/or atypically located ICM, an early stage of the disease when vegetations are not yet present, and the presence of prosthetic valves or cardiac device leads (9 -14) . In particular, with regard to prosthetic valves and cardiac device leads, these structures may cause acoustic shadowing and reverberation artifact, which can limit the detection of vegetations (11) (12) (13) . Moreover, due to the large distance between the echocardiographic probe and the tricuspid valve plane (far-field limitation), TEE may provide limited information and not visualize all tricuspid valve leaflets simultaneously (12) (13) (14) .
In our population, TEE failed to detect ICM when they were located on the right ventricle lead crossing the tricuspid valve. Several studies have reported suboptimal assessment of pacemaker leads and tricuspid valve with TEE due to their anterior location within the heart, far from the TEE transducer (11) (12) (13) (14) (15) . In these cases, ICE may provide better imaging of right-sided structures prosthetic devices (16) .
The current ESC and AHA guidelines suggest performing TEE for the diagnosis of IE due to its lower costs and feasibility (9,10), but our data showed that ICE, although an invasive tool, may reach a higher diagnostic yield, thus representing a valid option for overcoming some limitations linked to TEE. In fact, we found that ICE could detect vegetations in a larger number of high-risk patients compared with TEE, as well as when IE was suspected on the basis of extended criteria (including clinical and echocardiographic data). In particular, ICE had greater sensitivity for detecting small ICM localized in cardiac areas that are not easily scanned from TEE, such as the atrio-ventricular part of the right ventricular lead and the tricuspid valve. These results could be explained by the major resolution power of the intracardiac probe (9 MHz vs. 5 MHz) and its shorter distance from the leads and the tricuspid valve, as well as by the chance to freely orient the probe in any direction within the heart. Moreover, in patients with a diagnosis of ICM The y-axis shows the differences between the maximum length of ICM measured by TEE and ICE. The x-axis signifies the average of the maximum length of ICM measured by TEE and ICE. Abbreviations as in Figures 1 and 2 .
